Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

VYNE

Yarrow Bioscience, Inc.

CIK 0001566044 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$28.56
↑ 28.05 (5511.00%)
as of Jul 27, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$19.07M
P/E Ratio
-0.89
EPS
-0.62
Dividend Yield
2.7%
52W Position
100%
Beta
1.43

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.77
P/S
42.00
EV/Revenue
-12.25
ROE
-87.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

232 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 100%
$0.28$28.56

Latest Financials

2025-12-31 FY
Revenue
$570.00K
Net Income
-$26.48M
Total Assets
$30.16M
Free Cash Flow
–

Recent news